Arrowhead Pharma (ARWR) PT Raised to $123 at B.Riley
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $87.43 -2.21%
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
B.Riley analyst Chad L. Mabry raised the price target on Arrowhead Pharma (NASDAQ: ARWR) to $123.00 (from $101.00) while maintaining a Buy rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Analog Devices (ADI) PT Raised to $500 at JPMorgan
- Rubrik Inc (RBRK) PT Raised to $120 at Cantor Fitzgerald Into Q2 Earnings
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
